Condition

Mayer Rokitansky Kuster Hauser Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 4 Mayer Rokitansky Kuster Hauser Syndrome clinical trials that are recruiting, at sites in 3 countries (most in France (2), Belgium (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Mayer Rokitansky Kuster Hauser Syndrome clinical trials

StudyPhaseWhereStatusRegistered
Uterine transplant for women with infertility due to absence of uterus — Houston, Texas Recruiting Mar 2, 2022
Uterine transplantation from living donors for women with MRKH syndrome — Suresnes Recruiting Sep 28, 2018
Uterus transplantation from a deceased donor — Ghent Recruiting Aug 17, 2017
Understanding the genetic causes of Mayer-Rokitansky-Kuster-Hauser syndrome — Paris and 1 other locations Recruiting Nov 18, 2016

All recruiting trials (4)

Related topics

Infertility, FemaleInfertility of Uterine Origin

Quick answers

How many Mayer Rokitansky Kuster Hauser Syndrome clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in France (2 trials), Belgium (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.